Advertisement

Reactions Weekly

, Volume 1781, Issue 1, pp 84–84 | Cite as

Bendamustine/romidepsin

Various toxicities secondary to off-label use: 3 case reports
Case report
  • 15 Downloads

Reference

  1. Nachmias B, et al. Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma. Acta Haematologica 141: 216-221, No. 4, May 2019. Available from: URL: http://doi.org/10.1159/000498905 - IsraelCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations